One trial is investigating a potential biosimilar, or copy, of medication Trastuzumab (commonly known as Herceptin), and the other is looking at new ways of administering current medications Herceptin and Pertuzumab.
Gremlin key inclusion requirements:
Currently recruiting
Mango key inclusion requirements:
Not currently recruiting
Want to access a trial that's not in your area? It's not always possible, but if you're interested, email us at intouch@bcf.org.nz
Are we out of date? If you have updated or new information about a trial, we’d be grateful if you’d share it with us – email your update to intouch@bcf.org.nz
Subscribe for updates & stay in the loop with new studies.